Skip to content

Drug interactions

Baricitinib + Infliximab

Severity: Major

Baricitinib and Infliximab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Baricitinib should not be combined with biologic DMARDs such as infliximab because of additive immunosuppression. This raises the risk of serious infection, including opportunistic and reactivated infections.

What this interaction means in plain words

Baricitinib and Infliximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Baricitinib belongs to Musculoskeletal; Infliximab belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Additive immunosuppression from JAK inhibition and TNF-alpha blockade.

What to do

Avoid concurrent use; stop one agent before starting the other, following labeling and clinical judgment.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Baricitinib and Infliximab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Baricitinib with Infliximab?

MediHelp rates the interaction as major. Baricitinib and Infliximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Baricitinib should not be combined with biologic DMARDs such as infliximab because of additive immunosuppression. This raises the risk of serious infection, including opportunistic and reactivated infections.

How serious is the interaction between Baricitinib and Infliximab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use; stop one agent before starting the other, following labeling and clinical judgment.

What other medicines interact with Infliximab?

MediHelp also lists interactions of Infliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Infliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in